CA 19-9 Concentration in Peripheral and Portal Blood of Patients Operated on for Pancreatic Tumor
Journal Title: Polish Journal of Surgery - Year 2013, Vol 85, Issue 1
Abstract
Pancreatic cancer is one of the most common malignant diseases in the world. Morbidity rate increases and now reaches around 200 000 new cases yearly. Poor prognosis mainly results from usually late diagnosis and non-specific symptoms. Despite of advances in radiological diagnosis of pancreatic diseases, differentiation between malignant and inflammatory pancreatic tumors still remains difficult. The aim of the study was the assessment of clinical utility of CA 19-9 in peripheral and portal blood of patients with pancreatic tumor. Material and methods. 66 patients were hospitalized at the Department of General and Transplant Surgery between October 2010 nad July 2012 due to pancreatic tumor. Blood samples were collected from peripheral vein before surgery and intraoperatively from the portal vein to measure CA 19-9 concentration. 57 patients were diagnosed with malignant tumor and 9 with inflammatory lesion. Metastases to the liver were present in 7 of all patients. Radical surgery (Whipple’s procedure in 27 cases) were performed in 34 patients. Results. Significantly higher CA 19-9 concentration in the peripheral blood and in the portal blood as well was found in the pancreatic cancer group than in the inflammatory lesions group (51.2 vs <3 and 52.1 vs 6.3 respectively). Marker concentration in case of malignant lesions was significantly higher in the portal blood than in the peripheral blood (52.1 vs 51.2; p<0.05). CA 19-9 concentration of patients with malignant pancreatic tumors but without metastases to the liver was significanlty higher in the portal blood than in the peripheral blood (19.32 vs 18.65; p<0.01). Conclusions. Determination of the CA 19-9 concentration not only in the peripheral blood but in the portal blood as well might be a useful diagnostic tool in order to differentiate between the malignant and inflammatory pancreatic tumors. We did not see any statistically significant dependency between the CA 19-9 concentrations in the peripheral blood and portal blood and if the surgery was radical or not, but significantly higher concentrations of CA 19-9 in the portal blood than the peripheral blood among the patients suffering from the malignant pancreatic tumor without metastases to the liver might be useful tool when decisions on performing pancreatoduodenectomy are being made since this surgery is forborne from when metastases are present.
Authors and Affiliations
Krzysztof Szwedziak, Janusz Strzelczyk
Keywords
Related Articles
- EP ID EP74297
- DOI 10.2478/pjs-2013-0004
- Views 125
- Downloads 0
Rzadki przypadek izolowanej gruźlicy trzustki u 70-letniej pacjentki – opis przypadku
W niniejszej pracy opisaliśmy rzadki przypadek izolowanej gruźlicy trzustki u 70-letniej pacjentki, która została przyjęta do szpitala w celu przeprowadzenia diagnostyki guza zlokalizowanego w trzonie trzustki. Objawy kl...
Akceptacja choroby chorych na raka płuca przed i po zakończeniu leczenia chirurgicznego
Wprowadzenie: Rak płuca jest najczęstszym nowotworem złośliwym na świecie, a także jednym z najgorzej rokujących. Akceptacja choroby jest najważniejszym elementem w procesie przystosowania się do życia. Im wyższa, tym mn...
Polski konsensus w sprawie leczenia chorych na raka żołądka – aktualizacja 2017
Od roku 1986 kontynuowany jest projekt naukowy pt. „Polskie Badania nad Rakiem Żołądka”. Głównym celem tego projektu czyli wieloośrodkowych i interdyscyplinarnych badań jest poprawa wyników leczenia chorych na raka żołąd...
Association of Polymorphism of Lys589glu Exo1 Gene with the Risk of Colorectal Cancer in the Polish Population
The incidence of colorectal cancer (CRC) is increasing from year to year. Despite intensive research CRC etiology remains unknown. Studies suggest that at the basis of the process of carcinogenesis can lie reduced effici...
Polimorfizm genu CTRC może być czynnikiem zwiększającym ryzyko raka trzustki – badanie wstępne
Rak trzustki jest chorobą o wysokiej śmiertelności z powodu późnego rozpoznania i trudności w leczeniu. Cel: Celem badania była analiza mutacji wybranych genów SPINK1, CTRC, CFTR i PRSS1 oraz ich porównanie w tkance nowo...